H1710

· Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for H1710, covering 2025-07-23 to 2025-07-23. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study Evaluating H1710 for Injection in Participants With Advanced Solid Tumors [Phase 1]